Last $0.60 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

protea biosciences group inc (PRGB) Snapshot

Open
$0.70
Previous Close
$0.60
Day High
$0.70
Day Low
$0.60
52 Week High
04/29/14 - $5.00
52 Week Low
08/19/14 - $0.54
Market Cap
39.8M
Average Volume 10 Days
3.1K
EPS TTM
--
Shares Outstanding
66.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PROTEA BIOSCIENCES GROUP INC (PRGB)

Related News

No related news articles were found.

protea biosciences group inc (PRGB) Related Businessweek News

No Related Businessweek News Found

protea biosciences group inc (PRGB) Details

Protea Biosciences Group, Inc., a molecular information company, develops and commercializes proprietary life science technologies, products, and services to identify the molecules that are produced by living cells and various life forms. The company offers laser ablation electrospray ionization (LASEI), a bioanalytical instrument platform that enables the identification of proteins, lipids, and metabolites in tissue, cells, and biofluids, such as serum and urine without any sample preparation prior to analysis. It also provides bioanalytical consumable products for use in bioanalytical mass spectrometry, including Progenta surfactants that remove proteins out of biological samples and into liquid phase for analysis by mass spectrometry; single use products, comprising pipette tips and 96 well plates, which enables recovery of proteins from solutions, as well as removal of salts; and various protein mass spectrometry standards, that provide defined and characterized proteins representing protein structures and classes in order to enhance the reproducibility of a researcher’s bioanalytical mass spectrometry results. In addition, the company offers proprietary molecular information services for the discovery and identification of small and large molecules; and molecular data and informatics products. It primarily serves pharmaceutical and academic/clinical research laboratories, including analytical chemists, translational researchers, oncologists, pathologists, and cell biologists. The company was founded in 2001 and is based in Morgantown, West Virginia.

47 Employees
Last Reported Date: 04/7/14
Founded in 2001

protea biosciences group inc (PRGB) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $240.0K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $145.6K
Chief Science Officer and Director of Researc...
Total Annual Compensation: $146.2K
Vice President and General Manager
Total Annual Compensation: $240.0K
Compensation as of Fiscal Year 2013.

protea biosciences group inc (PRGB) Key Developments

Protea Biosciences Group, Inc Announces Resignation of Thijs Spoor as Member of the Board

Protea Biosciences Group Inc. announced the resignation of Thijs Spoor as member of the board of directors of the company, effective immediately.

Protea Biosciences Group, Inc and InSphero AG Enter Into Collaboration and Co-Marketing Agreement to Combine 3D Technologies

Protea Biosciences Group Inc. and InSphero AG jointly announced that they have entered into a collaboration that will combine each company's respective 3D technology. InSphero AG with models derived from liver, pancreas, tumor, and brain tissue that yield a high level of predictability during drug development compared to traditional 2-dimensional cell culture and other in vitro model systems. The collaboration will use Protea's proprietary LAESI(R) direct molecular imaging platform to analyze InSphero's proprietary 3D InSight(TM) microtissues, creating 3D molecular profiles for tissue characterization, drug metabolism and distribution, pharmacokinetic and toxicity applications. From this collaboration, Protea and InSphero expect to create new products and services that may be marketed to pharmaceutical and biotechnology researchers worldwide.

Protea Biosciences Group, Inc Announces Alzheimer's Research Collaboration with the University of Southampton, U.K

Protea Biosciences Group Inc. announced that it has entered into a research collaboration with the University of Southampton. The collaboration will partner Protea's proprietary direct molecular imaging technology and capabilities with a team of Alzheimer's researchers at the University of Southampton, to study the molecular mechanisms of the aged brain, in order to identify markers that may indicate risk of developing Alzheimer's disease.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRGB:US $0.60 USD 0.00

PRGB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PRGB.
View Industry Companies
 

Industry Analysis

PRGB

Industry Average

Valuation PRGB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 30.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 24.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROTEA BIOSCIENCES GROUP INC, please visit www.proteabio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.